Dáil Éireann Debate, Tuesday - 25 January 2022
628. Deputy Róisín Shortall asked the Minister for Health if there are specific guidelines and plans in place for treating Covid-19 in blood cancer patients similar to that which is provided for in the UK; and if he will make a statement on the matter. [3390/22]
Amharc ar fhreagraI am advised that a National Therapeutics Advisory Group has been established by the HSE to evaluate, advise, and provide recommendations on all therapeutics with potential for use in the treatment of COVID-19 in Ireland. This Group has developed clinical guidance and recommendations on the use of existing and emerging approved COVID-19 therapeutic medications, including Novel COVID-19 Antivirals and Novel COVID-19 Monoclonal Antibody Therapies. A Clinical Prioritisation Framework, that includes blood cancer patients, is being finalised and it is expected that it will shortly be made available publicly.
